4//SEC Filing
Grossi Federico 4
Accession 0001127602-22-005299
CIK 0001492422other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:29 PM ET
Size
4.4 KB
Accession
0001127602-22-005299
Insider Transaction Report
Form 4
Grossi Federico
See Remarks
Transactions
- Sale
Common Stock
2022-02-15$45.43/sh−375$17,036→ 106,086 total
Footnotes (1)
- [F1]This is a scheduled sale from 10B5-1 trading plan.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001720634
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 4:29 PM ET
- Size
- 4.4 KB